H.I.G. Capital Sells Soleo Health to Court Square Capital and WindRose Health Investors
- Editor
- Feb 3
- 1 min read
What's Happening: H.I.G. Capital, a global alternative investment firm with $67 billion in capital under management, has completed the sale of its portfolio company Soleo Health to funds managed by Court Square Capital and WindRose Health Investors. Soleo Health is a national provider of complex specialty pharmacy services and infusion therapy.
The Key Moves:
H.I.G. supported Soleo's expansion through de novo pharmacy and infusion suite openings
Soleo introduced a differentiated therapy-specific clinical model under H.I.G.'s ownership
The company diversified its payor, site-of-care, and therapy offerings during H.I.G.'s tenure
By The Numbers :
Soleo Health operates 26 pharmacies and over 30 ambulatory infusion suites across the United States
The company has pharmacy licensure in all 50 states
H.I.G. Capital has $67 billion of capital under management
Key Quotes:
Drew Walk, President and CEO of Soleo: "H.I.G. has been an exceptional partner to Soleo and instrumental in helping us build the Company into the market leader we are today."
Scott Zhu, Managing Director at H.I.G.: "Drew and the Soleo management team have done an outstanding job transforming Soleo from a regional infusion player into a national specialty care provider."
*KQ3*
The Bottom Line: H.I.G. Capital's successful exit from Soleo Health demonstrates the firm's ability to transform and grow healthcare companies. Under H.I.G.'s ownership, Soleo expanded its national presence, diversified its offerings, and strengthened its market position in the specialty pharmacy and infusion therapy sector.
Comments